Key facts
- · Type: New offering first sale 2026-03-27 · Amount sold: $11M · Total offering: $11M · SEC filing
- · Type: New offering first sale 2026-03-20 · Amount sold: $315K · Total offering: $315K · SEC filing
- · Type: New offering first sale 2026-03-12 · Amount sold: $237K · Total offering: $237K · SEC filing
- · Type: New offering first sale 2026-03-12 · Amount sold: $113K · Total offering: $113K · SEC filing
- · Type: New offering first sale 2026-01-30 · Amount sold: $500K · Total offering: $50.50M · SEC filing
Is ARTELO BIOSCIENCES, INC. a real, registered company?
ARTELO BIOSCIENCES, INC. is a registered filer with the SEC (CIK 1621221) and has filed since 2025-07-09. 8 filings are on record, the latest on 2026-04-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs ARTELO BIOSCIENCES, INC.?
ARTELO BIOSCIENCES, INC.'s filings name Connie Matsui, Douglas Blayney, Gregory Gorgas and 5 more as its officers, directors or promoters.
How much has ARTELO BIOSCIENCES, INC. raised?
Its new offerings report $26.78M sold across 8 offerings, as its own filings state.
Run the free check on ARTELO BIOSCIENCES, INC. →
SOLANA BEACH, CALIFORNIA
Biotechnology
8
$26.78M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-04-06 | New offering first sale 2026-03-27 | $11M | $11M | details · SEC filing |
| 2026-03-27 | New offering first sale 2026-03-20 | $315K | $315K | details · SEC filing |
| 2026-03-27 | New offering first sale 2026-03-12 | $237K | $237K | details · SEC filing |
| 2026-03-27 | New offering first sale 2026-03-12 | $113K | $113K | details · SEC filing |
| 2026-02-06 | New offering first sale 2026-01-30 | $500K | $50.50M | details · SEC filing |
| 2025-11-10 | New offering first sale 2025-10-28 | $3.72M | $3.72M | details · SEC filing |
| 2025-08-13 | New offering first sale 2025-08-05 | $9.47M | $9.47M | details · SEC filing |
| 2025-07-09 | New offering first sale 2025-06-26 | $1.43M | $1.43M | details · SEC filing |
Want the whole picture on ARTELO BIOSCIENCES, INC.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on ARTELO BIOSCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ARTELO BIOSCIENCES, INC. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from ARTELO BIOSCIENCES, INC.'s own filings with the SEC. The people those filings name are on the team page.